Moreover, the effectiveness of T2DM drugs, including metformin, sulfonylureas, dipeptidyl peptidase 4 (DPP-4) and sodium-glucose transport protein 2 (SGLT-2) inhibitors, may vary between individuals due to several factors including heredity, age, gender, hypertension and others [86]. This evidence concerns the gene DPP4 and hypertensive disorder.